CHMP4B | Charged multivesicular body protein 4B | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
RALY | RALY heterogeneous nuclear ribonucleoprotein | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
EIF2S2 | Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ITCH | Itchy E3 ubiquitin protein ligase | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
MAP1LC3A | Microtubule-associated protein 1 light chain 3 alpha | Predicted intracellular proteins
| | | | | Expressed in all |
NCOA6 | Nuclear receptor coactivator 6 | Predicted intracellular proteins
| | | | | Expressed in all |
PROCR | Protein C receptor, endothelial | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
EIF6 | Eukaryotic translation initiation factor 6 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ERGIC3 | ERGIC and golgi 3 | Predicted membrane proteins
| | | | | Expressed in all |
RBM12 | RNA binding motif protein 12 | Predicted intracellular proteins
| | | | | Expressed in all |
NFS1 | NFS1 cysteine desulfurase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
RBM39 | RNA binding motif protein 39 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MYL9 | Myosin, light chain 9, regulatory | Predicted intracellular proteins
| | | | | Expressed in all |
NDRG3 | NDRG family member 3 | Predicted intracellular proteins
| | | | | Expressed in all |
DSN1 | DSN1, MIS12 kinetochore complex component | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SAMHD1 | SAM domain and HD domain 1 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RBL1 | Retinoblastoma-like 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
SRSF6 | Serine/arginine-rich splicing factor 6 | Predicted intracellular proteins
| | | | | Expressed in all |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GTSF1L | Gametocyte specific factor 1-like | Predicted intracellular proteins
| | | | | Tissue enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
WISP2 | WNT1 inducible signaling pathway protein 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
YWHAB | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TOMM34 | Translocase of outer mitochondrial membrane 34 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
PI3 | Peptidase inhibitor 3, skin-derived | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEMG2 | Semenogelin II | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLPI | Secretory leukocyte peptidase inhibitor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RBPJL | Recombination signal binding protein for immunoglobulin kappa J region-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SDC4 | Syndecan 4 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
DBNDD2 | Dysbindin (dystrobrevin binding protein 1) domain containing 2 | Predicted intracellular proteins
| | | | | Expressed in all |
WFDC2 | WAP four-disulfide core domain 2 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNNC2 | Troponin C type 2 (fast) | Predicted intracellular proteins
| | | | | Tissue enriched |
CTSA | Cathepsin A | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
PCIF1 | PDX1 C-terminal inhibiting factor 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TP53RK | TP53 regulating kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PREX1 | Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | Predicted intracellular proteins
| | | | | Expressed in all |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CSE1L | CSE1 chromosome segregation 1-like (yeast) | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |